Opioid expenditures and utilization in the medicaid system

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 20, Issue 1, 2006, Pages 5-13

  Brixner, Diana I ^a,d   Oderda, Gary M ^b   Roland, Carl L ^a,b   Rublee, Dale A ^c  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Pharmacotherapy ^*  (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Costs; Medicaid spending; Opioid; Utilization

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; DEXTROPROPOXYPHENE; DEZOCINE; DIHYDROCODEINE; FENTANYL; FENTANYL CITRATE; FENTANYL DERIVATIVE; HYDROCODONE; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE DERIVATIVE; NALBUPHINE; NALOXONE; OPIATE; OXYCODONE; PENTAZOCINE; PETHIDINE;

ARTICLE; CHRONIC PAIN; COST UTILITY ANALYSIS; DATA ANALYSIS; DRUG ABUSE; DRUG COST; DRUG DOSAGE FORM; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; MEDICAID; PAIN; PATIENT CARE; PRESCRIPTION; REIMBURSEMENT; UTILIZATION REVIEW;

ANALGESICS, OPIOID; DRUG COSTS; DRUG UTILIZATION; HUMANS; MEDICAID; OUTPATIENTS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 33744960671     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1300/J354v20n01_03     Document Type: Article

References (13)

1. Herndon CM, Kalauokalani DA, Cunningham AJ, Jackson KC 2nd, Dunteman ED. Anticipating and treating opioid-associated adverse effects. Expert Opin Drug Saf. 2003 May; 2(3): 305-19
2. Cancer Pain Relief, World Health Organization. Geneva. 1986. p. 51.
3. Acute Pain Management Guideline Panel. Acute pain management: Operative or medical procedures and trauma. Clinical Practice Guideline. AHCPR Pub. No. 92-0032. Rockville, MD: Agency for Health Care Policy and Research. Public Health Service, U.S. Department of Health and Human Services, 1992.
4. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164(3): 305-312.
5. Kamal-Bahl SJ, Doshi JA, Stuart BC, Briesacher BA. Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries. J Am Geriatr Soc. 2003; 51(8): 1099-1104.
6. Kohn LT, Corrigan JM, Donaldson MS (eds.). To Err is Human-Building a Safer Health System, Committee on Quality of Health Care in America, Institute of Medicine Report, National Academy Press. Washington, DC, 1999.
7. Oderda GM. Evans RS, Lloyd J, Lipman A, Chen C, Ashburn M, Burke J, Samore M. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage. 2003; 25(3): 276-83.
8. Holahan J, Bruen B. Medicaid Spending: What Factors Contributed to the Growth Between 2000 and 2002? Kaiser Commission on Medicaid and the Uninsured, September 2003. Available at http://www.kff.org/. Accessed January 13, 2005.
9. Bruen B, Ghosh A, Medicaid Prescription Drug Spending and Use. Kaiser Commission on Medicaid and the Uninsured, June 2004. Available at http://www.kff.org/. Accessed January 13, 2005.
10. Opioid utilization analysis: FFS Medicaid Population in Oregon for 2000. http://pharmacy.oregonstate.edu/ drug_policy/reviews-evaluations/opioid.html. Accessed January 20, 2005.
11. CMS Data. Medicaid Enrollment and Beneficiaries. http://www.cms.hhs.gov/ researchers/pubs/datacompendium/ current/
12. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000 Jan: 19(1 suppl): S16-20.)
13. http://www.medsch.wise.edu/painpolicy/eguide2003/ index/eguide2003.pdf